Pletal sale

Adverse reactions were assessed in eight placebo-controlled clinical trials involving patients exposed to either 50 or 100 mg twice daily pletal n 1301 or placebo n 973 , with a median treatment duration of 127 days for patients on pletal and 134 days for patients on placebo.